Analytical Wizards, an Edison, New Jersey-based global healthcare analytics company, secured Series A funding from Sopris Capital.
The amount of the deal was not disclosed.
Founded in 2015 by Ram Sharma, CEO, Analytical Wizards leverages AI/ML technology, and domain expertise to provide solutions that drive value and accelerate business for clients in the pharmaceutical and biotech industries.
The company offers two proprietary platforms:
– WIZ, a multi-channel optimization platform, and
– IZE, a real world analytics platform that processes big data to enable analytics on demand and uses AI/ML to generate predictive, prescriptive insights and proactive triggers.
Analytical Wizards intends to use the funds to bolster product development efforts and accelerate the development of modules on the IZE platform that address analytical needs of Clinical Development and HEOR/Health Outcomes teams, in addition to those of Commercial Brand, Access, and Sales teams within pharma/biotech.
Jeff Kozloff, CEO of Trial Scope, an active entrepreneur and investor in the healthcare space has been an advisor to Analytical Wizards since inception, will join the Board of Directors along with Abinav Sankar, Vice President of Sopris Capital. Jaya Subramaniam, a veteran Pharma-Biotech executive, will join the Board of Directors and the company as its Chief Strategy Officer.